Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Cumberland Pharmaceuticals Inc. (CPIX) had Free Cash Flow per Share of $0.41 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$39.55M |
|
$-6.28M |
|
$6.07M |
|
$33.49M |
|
$49.11M |
|
$-9.55M |
|
$3.27M |
|
$-6.29M |
|
$-6.29M |
|
$-6.33M |
|
$-6.33M |
|
$-6.33M |
|
$-6.33M |
|
$-9.55M |
|
$-1.27M |
|
14.30M |
|
14.30M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$35.71M |
|
$0.37M |
|
$46.06M |
|
$81.78M |
|
$27.98M |
|
$12.78M |
|
$24.53M |
|
$52.52M |
|
$29.26M |
|
$5.74M |
|
$29.26M |
|
14.12M |
|
| Cash Flow Statement Financials | |
$6.09M |
|
$-0.11M |
|
$-7.42M |
|
$19.76M |
|
$18.32M |
|
$-1.44M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.28 |
|
-- |
|
-- |
|
0.30 |
|
0.44 |
|
84.66% |
|
-24.16% |
|
-24.16% |
|
-3.22% |
|
-15.89% |
|
-15.88% |
|
$5.81M |
|
-- |
|
-- |
|
-- |
|
0.48 |
|
1.32 |
|
4.05 |
|
90.05 |
|
-21.64% |
|
-110.33% |
|
-7.74% |
|
-15.06% |
|
$2.07 |
|
|
Free Cash Flow per Share |
$0.41 |
$0.43 |
|